Adjuvant treatment

COMBINATION_PRODUCT3 trials

Sponsors

Fujian Medical University Union Hospital, GERCOR - Multidisciplinary Oncology Cooperative Group, National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos

Conditions

ChemoradiotherapyChemotherapyChemotherapy Side EffectsDigestive CancerEsophageal Squamous Cell CarcinomaLow Anterior Resection SyndromeNeoadjuvant TherapyNeuroendocrine Carcinoma

Phase 2

Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas

RecruitingNCT04268121

GERCOR - Multidisciplinary Oncology Cooperative GroupDigestive Cancer, Neuroendocrine Carcinoma

Start: 2021-01-05End: 2031-01-31Target: 78Updated: 2025-07-23

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

RecruitingNCT06758830

National Cancer Center Affiliate of Vilnius University Hospital Santaros KlinikosChemoradiotherapy, Chemotherapy, Chemotherapy Side Effects +8

Start: 2025-01-07End: 2029-12-27Target: 400Updated: 2025-01-09

Phase 3

Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma

RecruitingNCT04009265

Fujian Medical University Union HospitalEsophageal Squamous Cell Carcinoma

Start: 2019-08-23End: 2027-07-01Target: 819Updated: 2021-11-12

Related Papers

Comparison of postoperative adjuvant therapy and surgery alone in pathological N1-2 esophageal squamous cell carcinoma: A prospective multi-center randomized controlled trial.

Journal of Clinical Oncology2025-05-28